Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Mesenchymal Stem Cell Therapy for Ischemic Stroke in Animal Model: A Systematic Review

The Indonesian Biomedical Journal · Vol. 15 No. 6 (2023) · hlm. 351–357

DOI
10.18585/inabj.v15i6.2460
ISSN
2085-3297, 2355-9179
Terbit
2023-12-11
Penerbit
Secretariat of The Indonesian Biomedical Journal
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc/4.0/

Abstrak

BACKGROUND: Stroke is one of many leading causes of death and disability worldwide. Despite decades of research, treatment for stroke recovery is still inadequate. Recently, mesenchymal stem cell (MSC) therapy is considered as one of the potential treatments for stroke due to their capabilities to repair or regenerate damaged tissues, as well as immunomodulators in inflammatory conditions. Many pre-clinical and clinical trials have shown MSC therapy feasibility, safety, and efficacy in treating stroke. However, evidence regarding the optimal treatment plan and factors that can improve stem cell functional outcomes in treating stroke needs to be further explored. Therefore, a systematic review was conducted.METHODS: Recent literatures from 2015-2022 regarding stem cell therapies, specifically MSC on ischemic stroke, were collected from two reliable databases: PubMed and PubMed Central. Collected literatures were properly applied to inclusion-exclusion criteria and appraised critically. Keyword strategies on databases were employed, including both medical subject headings (MeSH).RESULTS: Five literatures from 726 were identified and used for systematic review. All animal model in the literatures were prepared to have middle cerebral artery occlusion. All studies indicated that MSC therapy is a safe and reliable procedure despite the variety of transplantation routes. No report of toxicity, rejection reaction, nor infection on MSC treated groups.CONCLUSION: Stem cell sources, dosages, and delivery routes could be resourceful for future translational studies to ensure the safety and efficacy of MSC therapy for ischemic stroke.KEYWORDS: ischemic stroke, mesenchymal stem cells, regenerative medicine, immunomodulator

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 157 tautan kepenulisan bersama · 92 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Hasanuddin University
  • Padjadjaran University
  • PT Prodia StemCell Indonesia (Indonesia)
  • Dr. Hasan Sadikin General Hospital
  • Udayana University
  • University of Indonesia
  • Maranatha Christian University
  • Organisasi lain
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Anna MeilianaPadjadjaran University89
Nurrani Mustika DewiPadjadjaran University45
Suryani As’ádHasanuddin University14
Nisa ZulfaniPT Prodia StemCell Indonesia (Indonesia)7
Yani LinaHasanuddin University6
Gatot Susilo LawrenceHasanuddin University6
Albertus Budi SulistyaPadjadjaran University5
Geofanny FaciciliaPT Prodia StemCell Indonesia (Indonesia)5
Yussy Afriani DewiPadjadjaran University5
Ilhamjaya PatellongiHasanuddin University4
Anwar SantosoUdayana University4
Syakib BakriHasanuddin University4
Melisa Intan BarlianaPadjadjaran University4
Keri Lestari DandanPadjadjaran University4
Teguh RanakusumaUniversity of Indonesia3
Irawan YusufHasanuddin University3
Trilis YuliantiHasanuddin University3
Ida Paulina SorminHasanuddin University3
Erizal SugionoHasanuddin University3
Bayu Winata PuteraHasanuddin University3
Indriyanti Rafi SukmawatiHasanuddin University3
Mawar SubangkitIPB University3
Wahyu WidowatiMaranatha Christian University2
Yenny SurjawanHasanuddin University2
Irma Ruslina DefiPadjadjaran University2
Mansyur AriefHasanuddin University2
Andri HidayatHasanuddin University2
Irma Rahayu LatarissaPadjadjaran University2
Rina TrianaPadjadjaran University2
Angliana ChouwPT Prodia StemCell Indonesia (Indonesia)2

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S2764892910, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Mesenchymal Stem Cell Therapy for Ischemic Stroke in Animal Model: A Systematic Review</dc:title><dc:creator>Muhammad Agus Aulia</dc:creator><dc:creator>Keri Lestari</dc:creator><dc:creator>Ahmad Faried</dc:creator><dc:creator>Cynthia Retna Sartika</dc:creator><dc:creator>Andi Wijaya</dc:creator><dc:creator>Achmad Adam</dc:creator><dc:creator>Hanna Gunawan</dc:creator><dc:creator>Rima Haifa</dc:creator><dc:creator>N.F. Farah Naura</dc:creator><dc:creator>Billy Yosua Costantin Pongajow</dc:creator><dc:subject>mesenchymal stem cells</dc:subject><dc:subject>ischemic stroke</dc:subject><dc:subject>stem cell therapy</dc:subject><dc:subject>middle cerebral artery occlusion</dc:subject><dc:subject>animal models</dc:subject><dc:subject>transplantation route</dc:subject><dc:subject>stem cell safety</dc:subject><dc:subject>immunomodulation</dc:subject><dc:subject>regenerative medicine</dc:subject><dc:subject>stroke recovery</dc:subject><dc:description xml:lang="en">BACKGROUND: Stroke is one of many leading causes of death and disability worldwide. Despite decades of research, treatment for stroke recovery is still inadequate. Recently, mesenchymal stem cell (MSC) therapy is considered as one of the potential treatments for stroke due to their capabilities to repair or regenerate damaged tissues, as well as immunomodulators in inflammatory conditions. Many pre-clinical and clinical trials have shown MSC therapy feasibility, safety, and efficacy in treating stroke. However, evidence regarding the optimal treatment plan and factors that can improve stem cell functional outcomes in treating stroke needs to be further explored. Therefore, a systematic review was conducted.METHODS: Recent literatures from 2015-2022 regarding stem cell therapies, specifically MSC on ischemic stroke, were collected from two reliable databases: PubMed and PubMed Central. Collected literatures were properly applied to inclusion-exclusion criteria and appraised critically. Keyword strategies on databases were employed, including both medical subject headings (MeSH).RESULTS: Five literatures from 726 were identified and used for systematic review. All animal model in the literatures were prepared to have middle cerebral artery occlusion. All studies indicated that MSC therapy is a safe and reliable procedure despite the variety of transplantation routes. No report of toxicity, rejection reaction, nor infection on MSC treated groups.CONCLUSION: Stem cell sources, dosages, and delivery routes could be resourceful for future translational studies to ensure the safety and efficacy of MSC therapy for ischemic stroke.KEYWORDS: ischemic stroke, mesenchymal stem cells, regenerative medicine, immunomodulator</dc:description><dc:publisher>Secretariat of The Indonesian Biomedical Journal</dc:publisher><dc:date>2023-12-11</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>http://dx.doi.org/10.18585/inabj.v15i6.2460</dc:identifier><dc:identifier>10.18585/inabj.v15i6.2460</dc:identifier><dc:source>The Indonesian Biomedical Journal; Vol 15 No 6 (2023); 351-357</dc:source><dc:source>2085-3297</dc:source><dc:source>2355-9179</dc:source><dc:language>en</dc:language><dc:relation>https://inabj.org/index.php/ibj/article/download/2460/672</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc/4.0/</dc:rights></oai_dc:dc>